COMPARISON OF ACTIVE AND EXPECTANT MANAGEMENT OF PREGNANT WOMEN WITH NON-IMMUNE FETAL HYDROPS


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Aim. To compare perinatal outcomes of women with non-immune hydrops fetalis undergoing active and expectant management. Materials and methods. The study comprised all pregnant women with non-immune fetal hydrops, who were managed at the V.I. Kulakov NMRC for OG&P from 2015 to 2020 (n=45). Group 1 (n=30) included pregnant women with non-immune fetal hydrops, who were examined antenatally according to the developed protocol, and some of them received intrauterine treatment (prospective group from 2018 to 2020). Group 2 included 15 pregnant women who received no antenatal examination and treatment (retrospective group from 2015 to 2018). Results. In group 1, the causes of non-immune hydrops fetalis were identified antenatally in 83.3% (25/30) of patients, and in more than a half of them (56.7%), pregnancy management was based on these findings. In group 2, causes of non-immune hydrops fetalis were identified antenatally in 60% (9/15) of patients, and they received no intrauterine treatment. Patients with an active management approach had higher rates of antenatal resolution of non-immune hydrops and higher perinatal survival rates; their newborns had higher Apgar scores and a lower need for resuscitation, mechanical ventilation, and cardiotonic agents. Conclusion. Antenatal identification of non-immune fetal hydrops causes helps guide active pregnancy management, leading to improved perinatal outcomes.

Толық мәтін

Рұқсат жабық

Авторлар туралы

Faina Kadyrberdieva

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: f_kadyrberdieva@oparina4.ru
Ph.D. Student 117997, Russia, Moscow, Ac. Oparina str., 4

Roman Shmakov

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: r_shmakov@oparina4.ru
Dr. Med. Sci., Professor of the RAS, Director of the Institute of Obstetrics 117997, Russia, Moscow, Ac. Oparina str., 4

Ekaterina Bockeria

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: e_bokeriya@oparina4.ru
Dr. Med. Sci., Professor, Head of the 2nd Department of Pathology of Newborns and Premature Babies; Professor at the Department of Neonatology 117997, Russia, Moscow, Ac. Oparina str., 4

Kirill Kostyukov

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: k_kostyukov@oparina4.ru
Ph.D., Diagnostic Medical Sonographer at the Functional and Ultrasound Diagnostics 117997, Russia, Moscow, Ac. Oparina str., 4

Nana Tetruashvili

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: n_tetruashvili@oparina4.ru
Dr. Med. Sci., Head of the 2nd Obstetrics Department of Pathology of Pregnancy 117997, Russia, Moscow, Ac. Oparina str., 4

Әдебиет тізімі

  1. Sileo F.G., Kulkarni A., Branescu I., Homfray T., Dempsey E., Mansour S. et al. Non-immune fetal hydrops: etiology and outcome according to gestational age at diagnosis. Ultrasound Obstet. Gynecol. 2020; 56(3): 416-21. https://dx.doi. org/10.1002/uog.22019.
  2. Huang H., Tsay P.K., Chiang M.C., Lien R., Chou Y.H. Prognostic factors and clinical features in liveborn neonates with hydrops fetalis. Am. J. Perinatol. 2007; 24(1): 33-8. https://dx.doi.org/10.1055/s-2006-958158.
  3. Ota S., Sahara J., Mabuchi A., Yamamoto R., Ishii K., Mitsuda N. Perinatal and one-year outcomes of non-immune hydrops fetalis by etiology and age at diagnosis. J. Obstet. Gynecol. Res. 2016; 42(4): 385-91. https://dx.doi. org/10.1111/jog.12922.
  4. Norton M.E., Chauhan S.P, Dashe J.S. Society for Maternal-Fetal Medicine (SMFM). Society for maternal-fetal medicine (SMFM) clinical guideline#7: nonimmune hydrops fetalis. Am. J. Obstet. Gynecol. 2015; 212(2): 127-39. https://dx.doi.org/10.1016/j.ajog.2014.12.018.
  5. Bellini C., Hennekam R.C.M. Non-immune hydrops fetalis: a short review of etiology and pathophysiology. Am. J. Med. Genet. 2012; 158A(3): 597-605. https://dx.doi.org/10.1002/ajmg.a.34438.
  6. Santo S., Mansour S., Thilaganathan B., Homfray T., Papageorghiou A., Calvert S. et al. Prenatal diagnosis of non-immune hydrops fetalis: what do we tell the parents? Prenat. Diagn. 2011; 31(2): 186-95. https://dx.doi.org/10.1002/ pd.2677.
  7. Bellini C., Donarini G., Paladini D., Calevo M.G., Bellini T., Ramenghi L.A. et al. Etiology of non-immune hydrops fetalis: an update. Am. J. Med. Genet. A. 2015; 167A(5): 1082-8. https://dx.doi.org/10.1002/ajmg.a.36988.
  8. Abrams M., Meredith K., Kinnard P., Clark R. Hydrops fetalis: a retrospective review of cases reported to a large national database and identification of risk factors associated with death. Pediatrics. 2007; 120(1): 84-9. https://dx.doi. org/10.1542/peds.2006-3680.
  9. Кадырбердиева Ф.З., Шмаков Р.Г., Бокерия Е.Л., Тетруашвили Н.К., Костюков К.В. Эффективность применения алгоритма обследования на антенатальном этапе при неиммунной водянке плода. Акушерство и гинекология. 2020; 7: 71-8.
  10. Abbasi N., Ryan G. Fetal primary pleural effusions: prenatal diagnosis and management. Best Pract. Res. Clin. Obstet. Gynecol. 2019; 58: 66-77. https:// dx.doi.org/10.1016/ j.bp.obgyn.2019.01.005.
  11. Berger V.K., Sparks T.N., Jelin A.C., Derderian C., Jeanty C., Gosnell K. et al. Non-immune hydrops fetalis. Do placentomegaly and polyhydramnios matter? J. Ultrasound Med. 2018; 37(5): 1185-91. https://dx.doi.org/10.1002/ jum.14462.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2021

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>